Acetylcholine receptor expression in Merkel cell carcinoma

Area of Science:

• Oncology
• Neuroscience
• Dermatopathology

Background:

• Neurocrest-derived tissues express muscarinic and nicotinic acetylcholine receptors (mAChR and nAChR).
• These receptors are crucial for neurocrest cell development and migration.
• Recent studies show expression in melanoma and neuroendocrine tumors, prompting investigation in Merkel cell carcinoma (MCC).

Purpose of the Study:

• To investigate the immunohistochemical expression of mAChR and nAChR in primary cutaneous MCC.
• To explore the potential role of these receptors in MCC pathogenesis and as therapeutic targets.

Main Methods:

• Retrieved fifteen archival cases of primary non-metastatic cutaneous MCC.
• Utilized immunohistochemistry to evaluate M3, M5 mAChR, and beta 2 nAChR expression.
• Confirmed all cases prior to study by a board-certified dermatopathologist.

Main Results:

• All fifteen MCC cases showed diffuse positive staining for M3 and M5 mAChR.
• No immunohistochemical staining for beta 2 nAChR was observed in any case.
• MCC uniformly expresses M3 and M5 receptors, suggesting a potential role in tumor biology.

Conclusions:

• Merkel cell carcinoma (MCC) consistently expresses M3 and M5 muscarinic receptors.
• The absence of beta 2 nAChR suggests specific receptor involvement in MCC.
• M3 and M5 receptors, linked to cell proliferation and migration, represent potential therapeutic targets for MCC.